Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Curing Methods01:26

Curing Methods

183
Concrete members with a small surface-to-volume ratio are cured by oiling and moistening the forms before casting the concrete member. These forms can be left in place for a prolonged period to prevent moisture loss, and can be wetted if made of a material suitable for wetting. If the forms are removed early, the concrete member is moistened and covered with polythene sheets to maintain moisture. For large horizontal concrete surfaces exposed to dry weather, a temporary covering is suspended...
183
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

522
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
522
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.1K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

850
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
850
Cancer Therapies02:49

Cancer Therapies

9.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health-related Quality of Life With ARPIs in mHSPC: Insights From a Network Meta-analysis.

European urology focus·2026
Same author

Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials.

European urology oncology·2026
Same author

Population-adjusted network meta-analyses provide new insights into the efficacy of treatment alternatives for metastatic castration-sensitive prostate cancer.

Journal of comparative effectiveness research·2026
Same author

Efficacy and safety of treatments for metastatic castration-sensitive prostate cancer: A comprehensive network meta-analysis including final ARANOTE data.

Prostate cancer and prostatic diseases·2025
Same author

Cost-Utility Analysis of Subcutaneous Methotrexate in the Treatment of Patients with Rheumatoid Arthritis in the UK.

Advances in therapy·2025
Same author

Discovery and Development of a Small-Molecule Inhibitor Targeting the GAS41 YEATS Domain in Nonsmall Cell Lung Cancer.

Journal of medicinal chemistry·2025

Related Experiment Video

Updated: Nov 16, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.5K

Mixture Cure Models in Oncology: A Tutorial and Practical Guidance.

Federico Felizzi1, Noman Paracha2, Johannes Pöhlmann3

  • 1Value and Access and Commercial Development, Novartis Pharma AG, Fabrikstrasse 2, 4056, Basel, Switzerland. federico.felizzi@novartis.com.

Pharmacoeconomics - Open
|February 27, 2021
PubMed
Summary
This summary is machine-generated.

Mixture cure models offer improved long-term survival estimates for novel cancer therapies by accounting for a statistically cured patient fraction. This practical R tutorial details their implementation for accurate health economic evaluations.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.6K

Related Experiment Videos

Last Updated: Nov 16, 2025

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.5K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.1K
Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
09:20

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

8.6K

Area of Science:

  • Biostatistics
  • Cancer Research
  • Health Economics

Background:

  • Novel cancer therapies can lead to survival patterns where a fraction of patients achieve statistical cure.
  • Traditional survival analysis may not accurately capture long-term survival in such cases, impacting health economic evaluations.
  • Mixture cure models address this by estimating a 'cure fraction' within the patient population.

Purpose of the Study:

  • To provide a practical introduction and implementation guide for mixture cure models.
  • To demonstrate two approaches: an 'uninformed' model estimating cure fraction from data and an 'informed' model using external data.
  • To facilitate the accurate estimation of long-term survival for health economic analyses.

Main Methods:

  • Development and implementation of two mixture cure models in R.
  • Utilizing maximum likelihood estimation for fitting the models.
  • Step-by-step guidance on data handling, model fitting, and results interpretation.
  • Providing freely available R code on GitHub for reproducibility.

Main Results:

  • Mixture cure models provide different long-term survival estimates compared to standard methods, especially when a cure fraction exists.
  • The 'uninformed' approach estimates the cure fraction from trial data.
  • The 'informed' approach incorporates external data for the cure fraction, offering flexibility.
  • The models are presented as straightforward to use and interpret.

Conclusions:

  • Mixture cure models enhance the accuracy of long-term survival estimates for cancer therapies associated with statistical cure.
  • These models are crucial for reliable health economic evaluations, particularly with emerging cancer treatments.
  • The tutorial provides accessible tools and guidance for implementing and interpreting mixture cure models in R.